Centessa Pharmaceuticals
CNTA · NASDAQ
Price unavailable right now.
No price history for this range.
Who owns CNTA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 1.1% of CNTA’s shares.
- Goyal (Arjun)0.3%
- Cutter Capital Management, LP0.3%
- Chao (David M)0.1%
- Accardi (Mario Alberto)0.1%
- Next 6 largest institutions0.4%
- All other shareholders98.9%
| Holder | Shares | % of shares |
|---|---|---|
| Goyal (Arjun) | 462.58K | 0.30% |
| Cutter Capital Management, LP | 418.13K | 0.27% |
| Chao (David M) | 158.28K | 0.10% |
| Accardi (Mario Alberto) | 139.18K | 0.09% |
| T. Rowe Price International Ltd | 110.59K | 0.07% |
| Cubist Systematic Strategies, LLC | 103.91K | 0.07% |
| Bush (Tia L) | 100.98K | 0.07% |
| Pictet Asset Management (Japan) Ltd. | 93.68K | 0.06% |
| Saha (Saurabh) | 91.08K | 0.06% |
| Hussain (Iqbal J) | 57.72K | 0.04% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Eventide Healthcare & Life Sciences Fund | 668.14K | 0.43% |
| Arbitrage Fund | 518.60K | 0.34% |
| GMO Alternative Allocation Fund | 399.39K | 0.26% |
| Pictet Biopharmaceuticals Fund (Monthly Settlement) Non Hedged Course | 86.51K | 0.06% |
| Man Event Driven Alternative Fund | 41.33K | 0.03% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of CNTA in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| HUSSAIN IQBAL J | Other | 160.00K | — |
| HUSSAIN IQBAL J | Other | 175.00K | — |
| HUSSAIN IQBAL J | Other | 170.00K | — |
| HUSSAIN IQBAL J | Other | 100.00K | — |
| HUSSAIN IQBAL J | Other | 160.00K | — |
| HUSSAIN IQBAL J | Other | 100.00K | — |
| HUSSAIN IQBAL J | Other | 166.78K | — |
| HUSSAIN IQBAL J | Other | 221.56K | — |
| HUSSAIN IQBAL J | Other | 5.50K | — |
| HUSSAIN IQBAL J | Other | 117.64K | — |
Short interest
Settled Jun 15, 2026
- Shares short
- 1.61M
- Days to cover
- 1.16
- % of shares outstanding
- 1.04%
- Average daily volume
- 1.39M
- Change since last report
- −37.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.